BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs2300478
,
ERBB2
,
Angiogenesis
,
Breast Cancer
,
Adipose tissue
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
s100a7 protein, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Psoriasis skin lesions in a phase 1 trial of the anti-IL-17 monoclonal antibody LY2439821
Skin lesions (acute and chronic) of moderate-to-severe atopic dermatitis patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic…
Mutagenesis of the Loop 3 α-Helix of Neisseria gonorrhoeae TdfJ Inhibits S100A7 Binding and Utilizat…
cPLA2 blockade attenuates S100A7-mediated breast tumorigenicity by inhibiting the immunosuppressive …
S100A7 Co-localization and Up-regulation of Filaggrin in Human Sinonasal Epithelial Cells.
Psoriasin (S100A7) is increased in the serum of patients with moderate-to-severe psoriasis.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Colostrum on Mucosal Immunity in Very Low Birth Weight (VLBWs) Premature Infants
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ